Total Funding
$224.2M
Employee Range
11-50
DTx Pharma develops technology that will unleash RNA-based therapeutics as the modality of choice for personalized treatment across therapeutic areas. DTx Pharma believes its approach to delivering RNA medicines solves some of the issues that limited previous-generation platforms, including poor pharmacokinetics and insufficient cellular uptake.
DTx Pharma data powered by:
Share
DTx Pharma data powered by:
DTx PharmaOverall Ranking
DTx PharmaIndustry Rankings in
Healthtech
City Rank
Share
11th
In San Diego
Top 85%out of 13 exits
National Rank
Share
149th
In United States
Top 77%out of 194 exits
Regional Rank
Share
156th
In North America
Top 77%out of 204 exits
DTx PharmaSubindustry Rankings in
BiotechnologyCity Rank
Share
10th
In San Diego
Top 84%out of 12 exits
National Rank
Share
94th
In United States
Top 76%out of 124 exits
Regional Rank
Share
98th
In North America
Top 76%out of 129 exits
Special Awards
Exit Explorer
Had an exit eventrankings by:
DTx PharmaSB Rank Evolution
Not enough data points to display the chart.
DTx PharmaexitComparison
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...
See all ranked entities with a premium subscription
Get Pro